Skip to main content
. Author manuscript; available in PMC: 2022 Nov 19.
Published in final edited form as: J Alzheimers Dis. 2021;82(2):841–853. doi: 10.3233/JAD-210313

Figure 1. Illustration of quantified structural neuroimaging markers of cerebral small vessel disease.

Figure 1.

A) Cerebral microbleeds (CMB) identified on a susceptibility weighted imaging (SWI) sequence; B) Lacunes (arrows) and extensive white matter hyperintensity identified on a fluid-attenuated inversion recovery (FLAIR) sequence; C) Enlarged perivascular space (EPVS) in the basal ganglia identified on a T2 TSE sequence.